The absence of lymphoid suppressor cells in tumor-involved lymph nodes of patients with head and neck cancer.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Cellular Immunology

• Publication date

  1990-10-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0008-8749(90)90286-ZPMID 2145080
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Natural cytotoxicity of lymphocytes from lymph nodes draining breast carcinoma and its augmentation by interferon and OK432

  2004cited by this paper
• Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity

  2004cited by this paper
• Lymphokine-activated suppressor (LAS) cells in patients with gastric carcinoma

  2004cited by this paper
• Suppressor cells in the effector phase of autologous cytotoxic reactions in cancer patients

  2004cited by this paper
• Recombinant human granulocyte/macrophage colony-stimulating factor enhances monocyte cytotoxicity and secretion of tumor necrosis factor alpha and interferon in cancer patients.

  1989cited by this paper
• Biology, cytogenetics, and sensitivity to immunological effector cells of new head and neck squamous cell carcinoma lines.

  1989cited by this paper
• Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma

  1989cited by this paper
• The role of natural killer cells in human disease.

  1989cited by this paper
• Natural killer cell cytotoxicity in the peripheral blood, cervical lymph nodes, and tumor of head and neck cancer patients.

  1988cited by this paper
• Human cytotoxic T cells specific for autologous melanoma cells: successful generation from lymph node cells in seven consecutive cases.

  1988cited by this paper
• Inhibition of cytotoxicity to autologous tumor cells by the regional lymph node cells of patients with primary lung cancer.

  1987cited by this paper
• T cell suppressor factor from human glioblastoma cells is a 12.5‐kd protein closely related to transforming growth factor‐beta.

  1987cited by this paper
• Characterization of cells from invaded lymph nodes in patients with solid tumors. Lymphokine requirement for tumor-specific lymphoproliferative response

  1987cited by this paper
• Suppressor cell activity in melanoma-draining lymph nodes.

  1987cited by this paper
• Sequential effects of prostaglandins and interferon-gamma on differentiation of CD8+ suppressor cells.

  1987cited by this paper
• Relationship of the distribution of leu-2+ cells with suppressor cell activities in the spleen and lymphnodes from gastric cancer

  1987cited by this paper
• Variations in functional immunocompetence of individual tumor-draining lymph nodes in humans.

  1987cited by this paper
• Cell-mediated amplification and down regulation of cytotoxic immune response against autologous human cancer.

  1987cited by this paper
• Lymph node response and its relationship to prognosis in carcinomas of the head and neck.

  1987cited by this paper
• Presence of activated T-cells with a T8+ M1+ Leu 7+ surface phenotype in invaded lymph nodes from patients with solid tumors.

  1986cited by this paper
• Human esophageal carcinoma cell lines: prostaglandin production, biological properties, and behavior in nude mice.

  1986cited by this paper
• Systemic and regional natural cytotoxicity in patients with head and neck cancer.

  1986cited by this paper
• Tumor-specific suppressor T-cells which inhibit the in vitro generation of cytolytic T-cells from immune and early tumor-bearing host spleens.

  1986cited by this paper
• Regulation of cellular immune response against autologous human melanoma. II. Mechanism of induction and specificity of suppression.

  1986cited by this paper
• Functional properties of tumor-infiltrating and blood lymphocytes in patients with solid tumors: effects of tumor cells and their supernatants on proliferative responses of lymphocytes.

  1986cited by this paper
• Separation, phenotyping and limiting dilution analysis of T‐lymphocytes infiltrating human solid tumors

  1986cited by this paper
• Regulation of cellular immune response against autologous human melanoma. I. Evidence for cell-mediated suppression of in vitro cytotoxic immune response.

  1986cited by this paper
• Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins.

  1985cited by this paper
• Natural killer cell activity in tumor-draining lymph nodes: investigations in patients with malignant melanoma and head and neck cancer.

  1985cited by this paper
• Suppressor cells: permitters and promoters of malignancy?

  1979cited by this paper
• Immunobiology of head and neck cancer: basic concepts.

  1979cited by this paper
• Immunologic approaches to the diagnosis of cancer

  1976cited by this paper
• BIOLOGICAL EXPRESSIONS OF LYMPHOCYTE ACTIVATION

  1973cited by this paper

• Survival Advantage Following TAG-72 Antigen-Directed Cancer Surgery in Patients With Colorectal Carcinoma: Proposed Mechanisms of Action

  2021influential citation
• A treatise on endothelial biology and exosomes: homage to Theresa Maria Listowska Whiteside

  2020cites this paper
• Immuntherapie von Kopf-Hals-Karzinomen

  2013cites this paper
• Antigen-specific immunotherapy in head and neck cancer

  2013cites this paper
• The molecular genetics of laryngeal cancer.

  2008cites this paper
• Anti-tumor vaccines in head and neck cancer: targeting immune responses to the tumor.

  2007cites this paper
• General Principles of Tumor Immunotherapy

  2007cites this paper
• Vaccinations With Dendritic Cells Primed With Apoptotic Tumor Cells Can Elicit Preventive Antitumor Immunity in a Poorly Immunogenic Animal Model of Squamous Cell Carcinoma

  2007cites this paper
• The Local Tumor Microenvironment

  2007cites this paper
• Squamous Cell Carcinoma of the Head and Neck Human Cytotoxic T-Cell Lines with Restricted Specificity for Updated

  2006cites this paper
• [Squamous cell carcinoma of the head and neck. Principles and current concepts of immunotherapy].

  2005cites this paper
• Immune responses to p53 in patients with cancer:enrichment in tetramer+ p53 peptide-specific T cells and regulatory T cells at tumor sites

  2005cites this paper
• Therapy for oral squamous cell carcinoma by tegafur and streptococcal agent OK-432 in combination with radiotherapy: Association of the therapeutic effect with differentiation and apoptosis in the cancer cells

  2004cites this paper
• Targeting the immune system: novel therapeutic approaches in squamous cell carcinoma of the head and neck

  2004cites this paper
• Vaccinations with Dendritic Cells Can Elicit Preventive Immunity in a Squamous Cell Carcinoma Animal Model

  2004cites this paper
• Genetic engineering of TNF family protein-based vaccines for antitumor immunotherapy

  2004cites this paper
• Covalent linking of proteins and cytokines to suture: Enhancing the immune response of head and neck cancer patients

  2003cites this paper
• Current Status of Immunotherapy in Head and Neck Cancer

  2002cites this paper
• Immunobiology and immunotherapy of head and neck cancer

  2001cites this paper
• Cellular immunotherapy for patients with metastatic colorectal carcinoma using lymph node lymphocytes localized in vivo by radiolabeled monoclonal antibody

  1999cites this paper
• Who is in control of the immune system in head and neck cancer?

  1999cites this paper
• A different response pattern to interleukin-2 in regional lymph node lymphocytes and peripheral blood lymphocytes in patients with lung cancer

  1998cites this paper
• Variable expression of cytokines in human head and neck squamous cell carcinoma cell lines and consistent expression in surgical specimens.

  1998influential citation
• Antitumor response of regional lymph node lymphocytes in human lung cancer

  1998cites this paper
• Growth factors and cytokines in tumor invasion and metastasis

  1997cites this paper
• Increased recurrence and metastasis in patients whose primary head and neck squamous cell carcinomas secreted granulocyte‐macrophage colony‐stimulating factor and contained CD34+ natural suppressor cells

  1997cites this paper
• Mechanisms of immune suppression in patients with head and neck cancer: Influence on the immune infiltrate of the cancer

  1996cites this paper
• Causes of immunosuppression in squamous cell carcinoma of the head and neck.

  1996cites this paper
• Natural killer cells and cancer

  1996cites this paper
• Expression of activation-related molecules on regional lymph node lymphocytes in human lung cancer.

  1996cites this paper
• Proinflammatory Cytokines and the Host Response to Cancer

  1995cites this paper
• Immune parameters of mice bearing human head and neck cancer

  1995cites this paper
• Production by human squamous cell carcinoma of a factor inducing activation and proliferation of immune cells.

  1995cites this paper
• The Role of Immune Effector Cells in Immunotherapy of Head and Neck Cancer.

  1995cites this paper
• Immunology of Head and Neck Cancer

  1995cites this paper
• Grundlagen immunologischer Vorgänge beim Plattenepithelkarzinom im Kopf-Hals-Bereich — Diagnostik und Ursachen

  1995cites this paper
• Treating tumor-bearing mice with low-dose gamma-interferon plus tumor necrosis factor alpha to diminish immune suppressive granulocyte-macrophage progenitor cells increases responsiveness to interleukin 2 immunotherapy.

  1995cites this paper
• Mechanisms of immune suppression in patients with head and neck cancer: presence of CD34(+) cells which suppress immune functions within cancers that secrete granulocyte-macrophage colony-stimulating factor.

  1995cites this paper
• Intercellular adhesion molecule-1 expression by bladder cancer cells: functional effects.

  1994cites this paper
• Tumor-infiltrating lymphocytes: their phenotype, functions and clinical use

  1994cites this paper
• Localization of tumor‐reactive lymph node lymphocytes in vivo using radiolabeled monoclonal antibody

  1994cites this paper
• Production of interleukin-2 by EL4 tumor cells induces natural killer cell- and T-cell-mediated immunity.

  1994cites this paper
• T cell recognition of human tumors: implications for molecular immunotherapy of cancer.

  1993cites this paper
• Immunosuppression by retroviral-envelope-related proteins, and their role in non-retroviral human disease.

  1993cites this paper
• Immunology of head and neck cancer: perspectives.

  1993cites this paper
• Correspondence re: J. P. Alexander et al., T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors. Cancer Res., 53: 1380-1387, 1993.

  1993cites this paper
• Basic Science Reviews

  1992cites this paper
• Tumor-infiltrating lymphocytes

  1992cites this paper
• Expression of mRNA for cytokines in tumor‐infiltrating mononuclear cells in ovarian adenocarcinoma and invasive breast cancer

  1992cites this paper
• Role of cytokines in the adoptive immunotherapy of an experimental model of human head and neck cancer by human IL-2-activated natural killer cells.

  1992cites this paper
• Tumor-infiltrating lymphocytes. Potential and limitations to their use for cancer therapy.

  1992cites this paper
• Tumor-infiltrating lymphocytes as antitumor effector cells

  1992cites this paper
• Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancer.

  1991cites this paper
• Hierarchical Immunosuppression of Regional Lymph Nodes in Patients with Head and Neck Squamous Cell Carcinoma

  1991cites this paper
• Functional and phenotypic analysis of lymphocytes in head and neck cancer.

  1991cites this paper
• Antiproliferative effects of cytokines on squamous cell carcinoma.

  1991cites this paper